Company Overview of Tinea Pharmaceuticals, Inc.
Tinea Pharmaceuticals, Inc., a biopharmaceutical company, develops products for the treatment of onychomycosis or fungal infections of the toenail and nail bed. Its Luliconazole is a topical antifungal agent against a range of pathogens, including Trichophyton rubrum, Trichophyton mentagrophytes, and yeasts. The company was formerly known as Topica Pharmaceuticals, Inc. and changed its name to Tinea Pharmaceuticals, Inc. in September 2010. The company was founded in 2004 and is based in Palo Alto, California.
435 Tasso Street
Palo Alto, CA 94301-1555
Founded in 2004
Key Executives for Tinea Pharmaceuticals, Inc.
Tinea Pharmaceuticals, Inc. Key Developments
Similar Private Companies By Industry
|West Coast Fermentation Center, Inc.||United States|
|Gem Pharmaceuticals, LLC||United States|
|A&G Pharmaceutical, Inc.||United States|
|TEI Biosciences Inc.||United States|
|Neurotech Pharmaceuticals, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Tinea Pharmaceuticals, Inc., please visit www.topicapharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.